These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28390038)

  • 1. Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
    Gopal R; Selvarasu K; Pandian PP; Ganesan K
    Cell Oncol (Dordr); 2017 Jun; 40(3):219-233. PubMed ID: 28390038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of ACSM3 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.
    Ruan HY; Yang C; Tao XM; He J; Wang T; Wang H; Wang C; Jin GZ; Jin HJ; Qin WX
    Am J Cancer Res; 2017; 7(3):543-553. PubMed ID: 28401010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 4. Acyl-CoA Synthetase Medium-Chain Family Member 5-Mediated Fatty Acid Metabolism Dysregulation Promotes the Progression of Hepatocellular Carcinoma.
    Yang L; Pham K; Xi Y; Jiang S; Robertson KD; Liu C
    Am J Pathol; 2024 Oct; 194(10):1951-1966. PubMed ID: 39069168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis.
    Shrestha RK; Nassar ZD; Hanson AR; Iggo R; Townley SL; Dehairs J; Mah CY; Helm M; Alizadeh-Ghodsi M; Pickering M; Ghesquière B; Watt MJ; Quek LE; Hoy AJ; Tilley WD; Swinnen JV; Butler LM; Selth LA
    Cancer Res; 2024 Jul; 84(14):2313-2332. PubMed ID: 38657108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
    Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.
    Ramesh V; Ganesan K
    Int J Cancer; 2016 Oct; 139(7):1586-97. PubMed ID: 27194100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
    Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
    Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
    Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver ACSM3 deficiency mediates metabolic syndrome via a lauric acid-HNF4α-p38 MAPK axis.
    Xiao X; Li R; Cui B; Lv C; Zhang Y; Zheng J; Hui R; Wang Y
    EMBO J; 2024 Feb; 43(4):507-532. PubMed ID: 38191811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
    Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
    World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis.
    Sun XJ; Xu GL
    Med Sci Monit; 2017 Sep; 23():4343-4350. PubMed ID: 28887439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
    Ramesh V; Ganesan K
    Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HOX gene network in hepatocellular carcinoma.
    Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
    Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.
    Pan Q; Long X; Song L; Zhao D; Li X; Li D; Li M; Zhou J; Tang X; Ren H; Ding K
    Oncotarget; 2016 Jun; 7(25):38487-38499. PubMed ID: 27220887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
    Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
    J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.
    Zhang J; Baddoo M; Han C; Strong MJ; Cvitanovic J; Moroz K; Dash S; Flemington EK; Wu T
    Oncotarget; 2016 Aug; 7(31):49232-49245. PubMed ID: 27363021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.